{"lastClose": 1.0199999809265137, "len": 496, "date": "2023-03-08", "alpha_1": -0.8807044398491681, "beta_1": 0.14007576776191466, "drawup_1": 0.7325581218050006, "natr_1": 36.01231162387959, "sup_1": -0.4339869197020235, "res_1": 0.07222224819374548, "bullPattern_1": [], "bearPattern_1": ["BELTHOLD"], "rsi_1": 55.543233741400364, "adx_1": 26.60986581423512, "drawdown_1": -0.9048152301462742, "stratHoldSharpe_1": -1.5321808506763932, "stratHoldAlpha_1": 249.87783633711035, "stratHoldDrawdown_1": -0.840013866062819, "alpha_3mo": 2.122987077632735, "beta_3mo": -0.331156360292459, "drawup_3mo": 0.4117647223819081, "sharpe_3mo": -0.00860849078348946, "natr_3mo": 36.01231162387959, "sup_3mo": -0.08169938689025032, "res_3mo": 0.11111112409687274, "bullPattern_3mo": [], "bearPattern_3mo": ["BELTHOLD"], "rsi_3mo": 25.00000931322422, "adx_3mo": 52.36220131747632, "drawdown_3mo": -0.19811314176774342, "stratHoldSharpe_3mo": 0.019926541489538013, "stratHoldAlpha_3mo": 251.01144728829016, "stratHoldDrawdown_3mo": -0.17830182759096902, "Market Cap": 261544135, "Industry": "Biotechnology: In Vitro & In Vivo Diagnostic Substances", "Sector": "Health Care", "Name": "LumiraDx Limited", "Country": "Cayman Islands", "alpha%_1": 0.0038663069454338197, "beta%_1": 0.049964637560449526, "drawup%_1": 0.6869159520805217, "natr%_1": 1.0, "drawdown%_1": 0.002961058183110237, "stratHoldSharpe%_1": 0.011127646773313658, "stratHoldAlpha%_1": 3.982869770310908e-06, "stratHoldDrawdown%_1": 0.002527570542158893, "alpha%_3mo": 0.9449542224615103, "beta%_3mo": 0.012165849984407175, "drawup%_3mo": 0.8257901201109645, "sharpe%_3mo": 0.165024548572287, "natr%_3mo": 1.0, "drawdown%_3mo": 0.2504430511149539, "stratHoldSharpe%_3mo": 0.3325872486678325, "stratHoldAlpha%_3mo": 0.34746945469704144, "stratHoldDrawdown%_3mo": 0.26132999576536353}